Announcements Trials

Browse Landscape

Phase

Phase NA 24 Phase 4 5 Phase 3 4 Phase 2 3 Phase 2/3 2 Phase EARLY_PHASE1 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1 Gastrointestinal 1

Conditions

Colorectal Neoplasms 1

Interventions

Magnetic Resonance Spectroscopy 11 Oxaliplatin 9 Fluorouracil 9 Leucovorin 7 Irinotecan 7 Gemcitabine 7 Nivolumab 6 Biopsy 6 Bevacizumab 6 pembrolizumab 5 lenvatinib 5 Specimen Handling 5 Radiosurgery 5 Cisplatin 5 Capecitabine 5 X-Rays 4 Radiation 4 Proflavine 4 Oncolytic Virotherapy 4 Cyclophosphamide 4 Albumin-Bound Paclitaxel 4 130-nm albumin-bound paclitaxel 4 sodium thiosulfate 3 gallium 68 PSMA-11 3 folfirinox 3 Surgical Procedures, Operative 3 Paclitaxel 3 Omeprazole 3 Ketamine 3 Immune Checkpoint Inhibitors 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × Control Groups × Gastrointestinal × Clear all

NCT02304978 2025-12-26

TF

University Hospital, Lille

Phase EARLY_PHASE1 Completed

Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡